Plasma PARK7 and NDKA in acute stroke: methodological issues regarding diagnostic value.
作者信息
Sabour Siamak
机构信息
Department of Clinical Epidemiology, School of Health & Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Department of Epidemiology, Safety Promotions & Injury Prevention Research Centre, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
出版信息
Future Sci OA. 2019 Oct 30;5(10):FSO424. doi: 10.2144/fsoa-2019-0078.
Abstract
摘要
相似文献
1
Plasma PARK7 and NDKA in acute stroke: methodological issues regarding diagnostic value.急性卒中患者血浆中的帕金森蛋白7（PARK7）和N - 乙酰基 - D - 神经氨酸激酶（NDKA）：关于诊断价值的方法学问题
Future Sci OA. 2019 Oct 30;5(10):FSO424. doi: 10.2144/fsoa-2019-0078.
2
Comparison of plasma PARK7 and NDKA diagnostic value in acute stroke.血浆PARK7和NDKA在急性卒中诊断价值的比较。
Future Sci OA. 2019 Feb 12;5(5):FSO375. doi: 10.2144/fsoa-2018-0080. eCollection 2019 Jun.
3
Role of PARK7 and NDKA in stroke management: a review of PARK7 and NDKA as stroke biomarkers.PARK7和NDKA在中风治疗中的作用：关于PARK7和NDKA作为中风生物标志物的综述
Biomark Med. 2018 May;12(5):419-425. doi: 10.2217/bmm-2018-0013. Epub 2018 Apr 26.
4
PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke.PARK7和核苷二磷酸激酶A作为中风早期诊断的血浆标志物。
Clin Chem. 2005 Nov;51(11):2043-51. doi: 10.1373/clinchem.2005.053942. Epub 2005 Sep 1.
5
Plasmatic markers in hemorrhagic stroke.出血性卒中的血浆标志物
J Med Life. 2011 May 15;4(2):148-50. Epub 2011 May 25.
6
Serum biomarkers in patients suspected of transient ischaemic attack in primary care: a diagnostic accuracy study.基层医疗中疑似短暂性脑缺血发作患者的血清生物标志物：一项诊断准确性研究。
BMJ Open. 2019 Oct 17;9(10):e031774. doi: 10.1136/bmjopen-2019-031774.
7
Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer.血清核苷二磷酸激酶A用于检测结直肠癌的评估
Sci Rep. 2016 May 25;6:26703. doi: 10.1038/srep26703.
8
MRI for prediction of hemorrhagic transformation in acute ischemic stroke: a systematic review and meta-analysis.磁共振成像用于预测急性缺血性卒中出血性转化：一项系统评价和荟萃分析
Acta Radiol. 2020 Jul;61(7):964-972. doi: 10.1177/0284185119887593. Epub 2019 Nov 18.
9
Serum Sphingosine 1-Phosphate (S1P): A Novel Diagnostic Biomarker in Early Acute Ischemic Stroke.血清鞘氨醇-1-磷酸（S1P）：早期急性缺血性卒中的一种新型诊断生物标志物。
Front Neurol. 2020 Sep 8;11:985. doi: 10.3389/fneur.2020.00985. eCollection 2020.
10
The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.血清基质金属蛋白酶-9预测急性缺血性卒中后出血转化的准确性：一项系统评价和Meta分析
J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1653-1665. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.023. Epub 2018 Mar 26.
本文引用的文献
1
Comparison of plasma PARK7 and NDKA diagnostic value in acute stroke.血浆PARK7和NDKA在急性卒中诊断价值的比较。
Future Sci OA. 2019 Feb 12;5(5):FSO375. doi: 10.2144/fsoa-2018-0080. eCollection 2019 Jun.
2
An early diagnosis is not the same as a timely diagnosis of Parkinson's disease.早期诊断与帕金森病的及时诊断并不相同。
F1000Res. 2018 Jul 18;7. doi: 10.12688/f1000research.14528.1. eCollection 2018.
3
A Common Mistake in Assessing the Diagnostic Value of a Test: Failure to Account for Statistical and Methodologic Issues.评估一项检测诊断价值时的常见错误：未考虑统计和方法学问题。
J Nucl Med. 2017 Jul;58(7):1182-1183. doi: 10.2967/jnumed.115.156745. Epub 2017 Jan 12.
4
The validity and reliability of a signal impact assessment tool: statistical issue to avoid misinterpretation.
Pharmacoepidemiol Drug Saf. 2016 Oct;25(10):1215-1216. doi: 10.1002/pds.4061.
5
Validity and reliability of the new Canadian Nutrition Screening Tool in the 'real-world' hospital setting: Methodological issues.新型加拿大营养筛查工具在“真实世界”医院环境中的有效性和可靠性：方法学问题。
Eur J Clin Nutr. 2015 Jul;69(7):864. doi: 10.1038/ejcn.2015.69. Epub 2015 Apr 29.
6
Reliability of the ASA physical status scale in clinical practice: methodological issues.美国麻醉医师协会（ASA）身体状况量表在临床实践中的可靠性：方法学问题。
Br J Anaesth. 2015 Jan;114(1):162-3. doi: 10.1093/bja/aeu423.
7
Methodologic concerns in reliability of noncalcified coronary artery plaque burden quantification.非钙化冠状动脉斑块负荷定量可靠性中的方法学问题。
AJR Am J Roentgenol. 2014 Sep;203(3):W343. doi: 10.2214/AJR.14.12649.
Zotero 插件